UK markets open in 49 minutes
NIKKEI 225
38,459.53 -377.93 (-0.97%) HANG SENG
18,498.08 +53.97 (+0.29%) CRUDE OIL
73.21 -0.04 (-0.05%) GOLD FUTURES
2,357.90 +10.50 (+0.45%) DOW
38,711.29 +140.26 (+0.36%) Bitcoin GBP
55,562.48 +1,710.13 (+3.18%)
ResMed Inc. (RMD)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 207.39 |
| Open | 206.95 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 800 |
| Day's range | 206.61 - 212.23 |
| 52-week range | 132.24 - 229.97 |
| Volume | |
| Avg. volume | 1,106,142 |
| Market cap | 31.024B |
| Beta (5Y monthly) | 0.64 |
| PE ratio (TTM) | 32.49 |
| EPS (TTM) | 6.50 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | 1.92 (0.91%) |
| Ex-dividend date | 08 May 2024 |
| 1y target est | 212.34 |
ZacksHealthEquity (HQY) Q1 Earnings Surpass Estimates, Margins Up
HealthEquity (HQY) witnesses solid growth in HSAs, besides recording robust performances in all its segments, in the first quarter of fiscal 2025.
ZacksOmnicell (OMCL) Gains From New Offerings Amid Cost Woes
With the EnlivenHealth platform, Omnicell (OMCL) is gaining momentum with cross-selling and up-selling communication solutions to existing customers.
ZacksQIAGEN (QGEN) Advances Precision Medicine With New QIAseq Kit
QIAGEN (QGEN) launches the new QIAseq Multimodal DNA/RNA Lib Kit, facilitating multiomic studies and advancing precision medicine.
© 2024 Yahoo. All rights reserved.